HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.

Abstract
GG-62 is a cell line previously thought to be derived from an atypical Ewing tumor (ET). Reverse-transcriptase polymerase chain reaction revealed an in-frame fusion between the Ewing sarcoma gene ( EWS) codon 325 and the activating transcription factor 1 gene ( ATF1) codon 65 which permits the production of chimeric EWS-ATF1 oncoproteins. We also identified the genomic breakpoint resulting from a reciprocal t(12;22)(q13;q12), which is the hallmark of malignant melanoma of soft parts (MMSP). We applied Affymetrix human cancer G110 arrays to compare the gene expression patterns of GG-62 and other cell lines derived from small blue round cell tumors of childhood. Hierarchical clustering of 463 differentially expressed genes distinguished GG-62 from the ETs, as well as the neuroblastomas, and revealed a cluster of 36 upregulated genes. Several of these genes are involved in signal transduction pathways that may be critical for maintaining cell transformation; some examples are avian erythroblastic leukemia viral oncogene homolog 3 ( ERBB3), neuregulin 1 ( NRG1), fibroblast growth factor 9 ( FGF9), and fibroblast growth factor receptor-1 ( FGFR1). Furthermore, genes near the chromosome-12q13 breakpoint exhibited increased expression of GG-62 including ERBB3, NR4A1 (nuclear receptor subfamily 4, group A, member 1), cyclin-dependent kinase 2 ( CDK2), and alpha 5 integrin ( ITGA5). Altogether our findings demonstrate the MMSP derivation of GG-62 and may shed light on the mechanisms of tumorigenesis in this rare disease.
AuthorsKarl-Ludwig Schaefer, Daniel H Wai, Christopher Poremba, Eberhard Korsching, Frans van Valen, Toshifumi Ozaki, Werner Boecker, Barbara Dockhorn-Dworniczak
JournalVirchows Archiv : an international journal of pathology (Virchows Arch) Vol. 440 Issue 5 Pg. 476-84 (May 2002) ISSN: 0945-6317 [Print] Germany
PMID12021921 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Activating Transcription Factor 1
  • DNA-Binding Proteins
  • FGF9 protein, human
  • Fibroblast Growth Factor 9
  • Neuregulin-1
  • Oncogene Proteins, Fusion
  • Receptors, Fibroblast Growth Factor
  • S100 Proteins
  • Transcription Factors
  • Vimentin
  • Fibroblast Growth Factors
  • FGFR1 protein, human
  • Receptor Protein-Tyrosine Kinases
  • Receptor, ErbB-3
  • Receptor, Fibroblast Growth Factor, Type 1
Topics
  • Activating Transcription Factor 1
  • Adult
  • Bone Neoplasms (chemistry, genetics)
  • Chromosomes, Human, Pair 12
  • Chromosomes, Human, Pair 22
  • DNA-Binding Proteins
  • Female
  • Fibroblast Growth Factor 9
  • Fibroblast Growth Factors (genetics)
  • Fibula
  • Gene Expression
  • Humans
  • Melanoma (chemistry, genetics)
  • Musculoskeletal System
  • Neuregulin-1 (genetics)
  • Neuroblastoma (genetics)
  • Oligonucleotide Array Sequence Analysis
  • Oncogene Proteins, Fusion (genetics)
  • Receptor Protein-Tyrosine Kinases (genetics)
  • Receptor, ErbB-3 (genetics)
  • Receptor, Fibroblast Growth Factor, Type 1
  • Receptors, Fibroblast Growth Factor (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • S100 Proteins (analysis)
  • Sarcoma, Ewing (genetics)
  • Transcription Factors (genetics)
  • Translocation, Genetic
  • Tumor Cells, Cultured
  • Vimentin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: